JP2000513348A - 乳腺炎の予防と治療の方法 - Google Patents

乳腺炎の予防と治療の方法

Info

Publication number
JP2000513348A
JP2000513348A JP10502296A JP50229698A JP2000513348A JP 2000513348 A JP2000513348 A JP 2000513348A JP 10502296 A JP10502296 A JP 10502296A JP 50229698 A JP50229698 A JP 50229698A JP 2000513348 A JP2000513348 A JP 2000513348A
Authority
JP
Japan
Prior art keywords
microcosin
milk
antibiotic
mastitis
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP10502296A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000513348A5 (enExample
Inventor
ズーリ，ブルーノ
ジヨージズ，キヤサリン
ピール，ジヨン・エドマンドソン
Original Assignee
ノバルテイス・アクチエンゲゼルシヤフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルテイス・アクチエンゲゼルシヤフト filed Critical ノバルテイス・アクチエンゲゼルシヤフト
Publication of JP2000513348A publication Critical patent/JP2000513348A/ja
Publication of JP2000513348A5 publication Critical patent/JP2000513348A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/05—Treating milk before coagulation; Separating whey from curd
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
JP10502296A 1996-06-20 1997-06-19 乳腺炎の予防と治療の方法 Ceased JP2000513348A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96810415.8 1996-06-20
EP96810415 1996-06-20
PCT/EP1997/003212 WO1997048408A2 (en) 1996-06-20 1997-06-19 Method for the prevention and treatment of mastitis

Publications (2)

Publication Number Publication Date
JP2000513348A true JP2000513348A (ja) 2000-10-10
JP2000513348A5 JP2000513348A5 (enExample) 2005-02-10

Family

ID=8225635

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10502296A Ceased JP2000513348A (ja) 1996-06-20 1997-06-19 乳腺炎の予防と治療の方法

Country Status (14)

Country Link
US (1) US6187800B1 (enExample)
EP (1) EP0934075B1 (enExample)
JP (1) JP2000513348A (enExample)
CN (1) CN1119170C (enExample)
AT (1) ATE215378T1 (enExample)
AU (1) AU720243B2 (enExample)
BR (1) BR9709812A (enExample)
CA (1) CA2251779A1 (enExample)
DE (1) DE69711661T2 (enExample)
DK (1) DK0934075T3 (enExample)
ES (1) ES2175425T3 (enExample)
IL (1) IL126489A0 (enExample)
PT (1) PT934075E (enExample)
WO (1) WO1997048408A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007534717A (ja) * 2004-04-29 2007-11-29 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング 獣医学におけるメロキシカム製剤の使用
JP2016507533A (ja) * 2013-02-08 2016-03-10 ルオダ ファーマ ピーティーワイ リミテッド 乳房炎をはじめとする微生物感染を処置する方法
JP2016507532A (ja) * 2013-02-08 2016-03-10 ルオダ ファーマ ピーティーワイ リミテッド 局所微生物感染を処置する方法

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6638902B2 (en) * 2001-02-01 2003-10-28 Ecolab Inc. Stable solid enzyme compositions and methods employing them
EP1369425A1 (en) * 2001-03-13 2003-12-10 Yamanouchi Pharmaceutical Co. Ltd. Thiopeptide compounds
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
WO2004002451A1 (fr) * 2002-06-28 2004-01-08 Fang Chen Suppositoire a liberation controlee utilise dans un canal secreteur de lait
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ539076A (en) * 2005-03-29 2008-05-30 Blis Technologies Ltd Skin treatment compositions
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
CN100448480C (zh) * 2005-11-09 2009-01-07 北京大北农科技集团股份有限公司 治疗奶牛乳房炎的乳房用无菌粉针制剂及其制备方法
CN101547698B (zh) * 2006-10-10 2014-01-08 威斯康星旧生研究基金会 乳房内乳头密封剂和使用该制剂降低或消除成熟干酪中视觉缺陷的方法
JP5773983B2 (ja) 2009-04-08 2015-09-02 ウィスコンシン アルムニ リサーチ ファンデイション 乳房内乳頭シール剤及びその熟成チーズの外観上の欠陥を減少又は除去のための使用
WO2011046853A1 (en) * 2009-10-12 2011-04-21 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
EP2361632B1 (en) * 2010-02-19 2014-03-19 Protectimmun GmbH Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune diseases
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
TW201607534A (zh) * 2013-10-31 2016-03-01 皮拉馬爾企業有限公司 治療困難梭狀芽孢桿菌相關感染用硫肽化合物
BR112019012804A2 (pt) * 2016-12-27 2020-03-17 Colgate-Palmolive Company Composição antitranspirante/desodorante
GB202014427D0 (en) * 2020-09-14 2020-10-28 Norwegian Univ Of Life Sciences Composition and use
EP4342484A4 (en) * 2021-05-21 2025-04-16 A&J Science Co.,Ltd. Pharmaceutical composition comprising macrocosine compound and method for preparing macrocosine compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2169847C (en) * 1993-08-20 2006-02-14 John Edmondson Peel Method for the prevention and treatment of bovine mastitis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007534717A (ja) * 2004-04-29 2007-11-29 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング 獣医学におけるメロキシカム製剤の使用
JP2016507533A (ja) * 2013-02-08 2016-03-10 ルオダ ファーマ ピーティーワイ リミテッド 乳房炎をはじめとする微生物感染を処置する方法
JP2016507532A (ja) * 2013-02-08 2016-03-10 ルオダ ファーマ ピーティーワイ リミテッド 局所微生物感染を処置する方法

Also Published As

Publication number Publication date
IL126489A0 (en) 1999-08-17
AU3341097A (en) 1998-01-07
EP0934075B1 (en) 2002-04-03
PT934075E (pt) 2002-08-30
ES2175425T3 (es) 2002-11-16
EP0934075A2 (en) 1999-08-11
DE69711661D1 (de) 2002-05-08
ATE215378T1 (de) 2002-04-15
CN1222081A (zh) 1999-07-07
DE69711661T2 (de) 2002-10-17
BR9709812A (pt) 1999-08-10
AU720243B2 (en) 2000-05-25
DK0934075T3 (da) 2002-06-10
CN1119170C (zh) 2003-08-27
CA2251779A1 (en) 1997-12-24
US6187800B1 (en) 2001-02-13
WO1997048408A3 (en) 1998-02-19
WO1997048408A2 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
JP2000513348A (ja) 乳腺炎の予防と治療の方法
Calvinho et al. Potential virulence factors of Streptococcus dysgalactiae associated with bovine mastitis
US6254881B1 (en) Antiinfective free intramammary veterinary composition
Lacy-Hulbert et al. Physical characteristics of the bovine teat canal and their influence on susceptibility to streptococcal infection
EP0323109B1 (en) Treatment of mastitis and applicator therefor
CN101795707A (zh) 用于微生物贮藏和递送的组合物和方法
Owens et al. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation
CN104379151A (zh) 药物组合物和乳腺炎的治疗
McDonald Streptococcal and staphylococcal mastitis
JP3670280B2 (ja) ウシの乳房炎の予防および治療方法
Naccari et al. Therapeutic efficacy of tilmicosin in ovine mammary infections
JP2004501973A (ja) 乳房炎の治療および予防のための方法
JP6921805B2 (ja) ウシ乳腺炎の治療に使用するためのリソバクチン
EP0759077A1 (en) Lanthionine-containing antimicrobial compound
Ziv et al. Clinical pharmacology of cephacetrile in ruminants
Østerås et al. The influence of iodine teat dipping and an external teat sealant in heifers on bacterial isolation from quarter milk culture obtained post-calving
Oliver Growth of Staphylococcus aureus and Streptococcus species in bovine mammary secretions during the nonlactating and peripartum periods following intramammary infusion of lipopolysaccharide at cessation of milking
Owens et al. The postantibiotic effect of selected antibiotics on Staphylococcus aureus Newbould 305 from bovine intramammary infection
Oliver An attempt to alter the rate of involution and the natural resistance to infection in the bovine mammary gland by infusion of endotoxin

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040618

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040618

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070619

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20071107

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080108